Evidence map›Paper›PMID 29198943›Full record

ArticleBiochimica et biophysica acta. Biomembranes2018

Human bile acid transporter ASBT (SLC10A2) forms functional non-covalent homodimers and higher order oligomers.

Paresh P Chothe, Lindsay C Czuba, Robyn H Moore, Peter W Swaan

Abstract read
In one paragraph

Article in Biochimica et biophysica acta. Biomembranes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. The Journal of biological chemistry · 2020
    Article
  6. Review
  7. Article
  8. Review
  9. A novel bioluminescence-based method to investigate uptake of bile acids in living cells.American journal of physiology. Gastrointestinal and liver physiology · 2018
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Paresh P ChotheDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 20 Penn Street, Baltimore, MD 21201, USA.
Lindsay C CzubaDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 20 Penn Street, Baltimore, MD 21201, USA.
Robyn H MooreDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 20 Penn Street, Baltimore, MD 21201, USA.
Peter W SwaanDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 20 Penn Street, Baltimore, MD 21201, USA. Electronic address: pswaan@rx.umaryland.edu.
University of Maryland, Baltimore · US

Funding

Structural Biology of the Apical Bile Acid Transporter.R01DK061425 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI SWAAN, PETER W · 2003 to 2020
$4.6M
Epithelial Transport and Function of RiboflavinR01DK056631 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI SWAAN, PETER W · 2001 to 2003
$597k
NIDDK NIH HHS R01 DK056631NIDDK NIH HHS R01 DK061425
6 · The paper itself

Abstract

The human apical sodium-dependent bile acid transporter, hASBT/SLC10A2, plays a central role in cholesterol homeostasis via the efficient reabsorption of bile acids from the distal ileum. hASBT has been shown to self-associate in higher order complexes, but while the functional role of endogenous cysteines has been reported, their implication in the oligomerization of hASBT remains unresolved. Here, we determined the self-association architecture of hASBT by site-directed mutagenesis combined with biochemical, immunological and functional approaches. We generated a cysteine-less form of hASBT by creating point mutations at all 13 endogenous cysteines in a stepwise manner. Although Cysless hASBT had significantly reduced function correlated with lowered surface expression, it featured an extra glycosylation site that facilitated its differentiation from wt-hASBT on immunoblots. Decreased protein expression was associated with instability and subsequent proteasome-dependent degradation of Cysless hASBT protein. Chemical cross-linking of wild-type and Cysless species revealed that hASBT exists as an active dimer and/or higher order oligomer with apparently no requirement for endogenous cysteine residues. This was further corroborated by co-immunoprecipitation of differentially tagged (HA-, Flag-) wild-type and Cysless hASBT. Finally, Cysless hASBT exhibited a dominant-negative effect when co-expressed with wild-type hASBT which validated heterodimerization/oligomerization at the functional level. Combined, our data conclusively demonstrate the functional existence of hASBT dimers and higher order oligomers irrespective of cysteine-mediated covalent bonds, thereby providing greater understanding of its topological assembly at the membrane surface.

Indexed as

Amino Acid SequenceAnimalsBiological TransportCell MembraneChlorocebus aethiopsCOS CellsCysteineCystineGenes, DominantGlycosylationHumansImmunoprecipitationMutagenesis, Site-DirectedOrganic Anion Transporters, Sodium-DependentPeptide FragmentsProteasome Endopeptidase ComplexCysteineCystineOrganic Anion Transporters, Sodium-DependentPeptide FragmentsProteasome Endopeptidase ComplexRecombinant Proteinssodium-bile acid cotransporterSymportersTaurocholic AcidBile acidEpitope tagIntestinal absorptionTransporter

Identifiers

PMID29198943
PMCPMC5780253
OpenAlexW2771763633

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.